Uciane Scarlett
Stealth
United States
Cambridge
Biotechnology
Venture Capital, Lifesciences, Oncology, Strategy, Start-ups, Clinical Research, Investments, Entrepreneurship, Immunology, Business Development, Life Sciences, Biotechnology, Clinical Development, Research, Vaccines, Laboratory, Molecular Biology, Healthcare, Cancer, Portfolio Management
Experience
Stealth
Stealth
Cambridge, Massachusetts, United States
Principal
MPM BioImpact
Greater Boston
Fund management - oversaw INV fund ($100M) Company Creation/Operations/Financing: ashibio (Head Corp Dev), Crane BioTherapeutics (interim CEO) Boards: Crane BioTherapeutics, TUO Therapeutics, ProRavel
Principal
Oxford Science Enterprises
Fund management - co-lead life science vertical (2/3 of fund), company creation, portfolio management Company Creation/Operations/Financing: T-Cypher Bio (interim Exec Chair), PepGen, ORFonyx, Alethiomics, Endlyz Boards: T-Cypher Bio, PepGen (NASDAQ: PEPG), Miro Bio (acq. by Gilead), DJS (acq. by AbbVie), Scenic Bio
Associate
Atlas Venture
Boston, Massachusetts, United States
Life science investing, company creation, portfolio company operations. Company Creation/Board: Dyne Therapeutics, Quench Bio, Navitor Operations: Dyne Therapeutics, Quench Bio, Korro Bio, AVRO BIO
Director of Business Development & Strategy
Compass Therapeutics Inc.
Drove business development & corporate/pipeline strategy; participated in venture financing; conceptualized strategic academic partnership; presented to BoD; engaged with various bankers, analysts, VCs
Manager
Clarion | A Life Sciences Consultancy
Corporate/pipeline strategy, early commercial strategy, business development; strong oncology focus Drove internal initiatives geared towards growing Clarion's oncology business Published two articles (business journal & peer-reviewed journal) in oncology
Postdoctoral Fellow
The Wistar Institute
Education
Geisel School of Medicine at Dartmouth
Cancer Immunology
Immunotherapy, immunobiology, and novel diagnostics for ovarian cancer • Immunotherapy combinations validated preclinically: CD40 and TLR agonists • Demonstrated role of immunosuppressive dendritic cells in progression of cancer • Transgenic mouse developed using microscopic technique • Investigated a novel diagnostic approach using iron nano-particles • Collaborated on thesis lab research involving PD-L1 and adoptive T-cell therapies • Initiated numerous collaborations across different disciplines, e.g. Engineering • First and co-author of thirteen (13) scientific publications in prominent peer-reviewed journals
The University of the West Indies, Mona
Biotechnology, Zoology
The Tuck School of Business at Dartmouth
• In class: Contemporary Issues in Healthcare & Introduction to Entrepreneurship • On-line: Financial Accounting
Uciane Scarlett's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.